Eric Topol on Twitter
Covid19-Sources
412 Athlete Cardiac Arrests, Serious Issues, 242 Dead, After COVID Shot
PolitiFact - Dozens of prominent athletes did not die of heart attacks after COVID-19 vaccination
Do vaccines protect from long COVID?
Association Between COVID-19 and Myocarditis...
Was ist Long COVID?
Coronavirus (COVID-19) Infection Survey, characteristics of people testing positive for COVID-19, UK - Office for National Statistics
NIH study uncovers blood vessel damage and inflammation in COVID-19
Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials
Reinfections in Israel
OrthopaeDenker on Twitter
Valneva: Positive Phase 3 Results for COVID-19 Vaccine
The benefits, costs and feasibility of a low incidence COVID-19 strategy
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies
Amelie Thobaben on Twitter
ab September 2021 - Prophezeiungen der Querdenker
SARS-CoV-2 variants of concern and variants under investigation- Technical briefing 34 - technical-briefing-34-14-january-2022.pdf
Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021
Kidney Outcomes in Long COVID
Eric Feigl-Ding on Twitter
COVID vaccines safely protect pregnant people: the data are in
COVID-19 vaccine surveillance report - week 2 - Vaccine-surveillance-report-week-2-2022.pdf
SARS-CoV-2 Impfung - Mythen und Fakten
Charité-Virologe Drosten im Interview: „Wie lange geht diese Quälerei noch weiter?“
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections | NEJM
Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain
US Insurer Spending on Ivermectin Prescriptions for COVID-19
Biomarker weist frühzeitig auf schwere COVID-19-Verläufe hin
Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial